Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Preferred Dividend Payments (2020)

Kymera Therapeutics (KYMR) has disclosed Preferred Dividend Payments for 1 consecutive years, with -$50000.0 as the latest value for Q2 2020.

  • For Q2 2020, Preferred Dividend Payments changed N/A year-over-year to -$50000.0; the TTM value through Dec 2020 reached $9.0 million, changed N/A, while the annual FY2020 figure was $9.0 million, N/A changed from the prior year.
  • Preferred Dividend Payments hit -$50000.0 in Q2 2020 for Kymera Therapeutics, down from $9.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $9.1 million in Q1 2020 and bottomed at -$50000.0 in Q2 2020.